(Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -21.73%5.15B | 6.21%25.09B | 12.42%19.57B | 20.31%13.47B | 28.29%6.58B | -14.57%23.62B | -22.85%17.41B | -36.79%11.2B | -25.29%5.13B | 4.34%27.65B |
Operating income | -21.73%5.15B | 6.21%25.09B | 12.42%19.57B | 20.31%13.47B | 28.29%6.58B | -14.57%23.62B | -22.85%17.41B | -36.79%11.2B | -25.29%5.13B | 4.34%27.65B |
Operating expenses | 18.65%-4.37B | 0.75%-20.33B | -4.10%-15.89B | -9.25%-10.86B | -16.58%-5.37B | 16.74%-20.48B | 24.19%-15.26B | 37.56%-9.94B | 24.44%-4.6B | -6.81%-24.6B |
Gross profit | -35.33%786.47M | 51.61%4.76B | 71.64%3.68B | 108.25%2.6B | 130.48%1.22B | 2.96%3.14B | -11.77%2.14B | -29.89%1.25B | -31.98%527.64M | -12.13%3.05B |
Selling expenses | -1.12%-152.58M | -28.70%-677.52M | -27.51%-532.25M | -37.50%-362.63M | -30.54%-150.89M | 27.81%-526.43M | 21.37%-417.41M | 31.21%-263.72M | 31.24%-115.59M | -9.54%-729.25M |
Administrative expenses | 17.83%-237.9M | -32.30%-1.37B | -41.40%-922.95M | -59.12%-634.02M | -58.50%-289.53M | -18.40%-1.03B | 1.97%-652.72M | 10.94%-398.44M | 11.81%-182.67M | -0.39%-873.18M |
Research and development expenses | 44.33%-51.01M | -29.76%-396.52M | -18.02%-266.97M | -16.29%-169.67M | -32.92%-91.62M | 23.19%-305.58M | 26.04%-226.21M | 23.12%-145.9M | 15.59%-68.93M | -7.11%-397.82M |
Profit from asset sales | 156.29%1.38M | -94.51%12.32M | 97.93%-196.78K | 87.61%-1.07M | -789.20%-2.45M | 26.57%224.18M | -105.34%-9.49M | -104.94%-8.61M | -0.46%355.51K | 205.46%177.12M |
Revaluation surplus | -111.28%-4.97M | 98.65%-99.44K | 132.34%11.47M | 57.53%-3.98M | -258.46%-2.35M | 63.69%-7.35M | -176.24%-35.48M | -2,310.26%-9.38M | 106.29%1.48M | -255.43%-20.23M |
-Changes in the fair value of other assets | -111.28%-4.97M | 98.65%-99.44K | 132.34%11.47M | 57.53%-3.98M | -258.46%-2.35M | 63.69%-7.35M | -176.24%-35.48M | -2,310.26%-9.38M | 106.29%1.48M | -255.43%-20.23M |
Impairment and provision | 45.01%-8M | -184.83%-196.23M | -169.19%-95.84M | -418.55%-93.75M | -30.68%-14.55M | -1.99%-68.89M | 54.01%-35.6M | 80.17%-18.08M | 56.89%-11.14M | 54.54%-67.55M |
-Other impairment is provision | 45.01%-8M | -184.83%-196.23M | -169.19%-95.84M | -418.55%-93.75M | -30.68%-14.55M | -1.99%-68.89M | 54.01%-35.6M | 80.17%-18.08M | 56.89%-11.14M | 54.54%-67.55M |
Special items of operating profit | -50.53%4.63M | 2,093.08%1.16B | 1,884.99%1.12B | 3,020.46%1.13B | -68.31%9.37M | -65.23%53.05M | -51.59%56.67M | -62.75%36.37M | -6.86%29.56M | -43.36%152.6M |
Operating profit | -51.32%318.87M | 131.33%3.2B | 287.10%2.93B | 505.63%2.43B | 301.84%655.06M | 16.06%1.38B | -27.95%757.31M | -54.77%401.29M | -42.10%163.02M | -27.11%1.19B |
Financing cost | 2,256.60%42.2M | -24.84%68.34M | -27.73%68.24M | -0.59%52.26M | -166.75%-1.96M | 638.05%90.93M | 1,129.09%94.42M | 695.00%52.58M | 175.61%2.93M | 87.42%-16.9M |
Special items of earning before tax | -19.56%1.07M | -282.62%-3.91M | 220.26%5.01M | 96.59%4.14M | 0.01%1.33M | -16.69%2.14M | -56.95%1.56M | -35.02%2.1M | -60.96%1.33M | -86.35%2.57M |
Earning before tax | -44.66%362.14M | 121.10%3.26B | 252.14%3B | 445.38%2.49B | 291.22%654.43M | 25.39%1.47B | -18.38%853.3M | -48.28%455.97M | -40.48%167.28M | -22.50%1.18B |
Tax | 49.13%-92.54M | -125.10%-813M | -289.74%-734.17M | -594.34%-594.83M | -373.13%-181.91M | -91.60%-361.17M | -5.26%-188.38M | 29.18%-85.67M | 20.07%-38.45M | 24.10%-188.5M |
After-tax profit from continuing operations | -42.94%269.6M | 119.80%2.45B | 241.49%2.27B | 410.91%1.89B | 266.78%472.52M | 12.75%1.11B | -23.26%664.92M | -51.32%370.31M | -44.70%128.83M | -22.19%987.66M |
Earning after tax | -42.94%269.6M | 119.80%2.45B | 241.49%2.27B | 410.91%1.89B | 266.78%472.52M | 12.75%1.11B | -23.26%664.92M | -51.32%370.31M | -44.70%128.83M | -22.19%987.66M |
Minority profit | 167.65%4.71M | -81.78%-7.91M | -260.08%-6.65M | -200.91%-4.59M | -259.49%-6.96M | -105.01%-4.35M | -94.82%4.15M | -93.70%4.55M | -85.49%4.37M | -36.93%86.91M |
Profit attributable to shareholders | -44.76%264.89M | 119.66%2.46B | 244.64%2.28B | 418.52%1.9B | 285.25%479.49M | 24.11%1.12B | -15.98%660.77M | -46.87%365.76M | -38.65%124.46M | -20.40%900.75M |
Basic earnings per share | -45.83%0.13 | 121.82%1.22 | 242.42%1.13 | 422.22%0.94 | 300.00%0.24 | 14.58%0.55 | -23.26%0.33 | -53.85%0.18 | -45.45%0.06 | -25.00%0.48 |
Diluted earnings per share | -45.83%0.13 | 121.82%1.22 | 242.42%1.13 | 422.22%0.94 | 300.00%0.24 | 14.58%0.55 | -23.26%0.33 | -53.85%0.18 | -45.45%0.06 | -25.00%0.48 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers | -- | -- | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data